Opened 171 days ago
Closes 31 December 2023
Study Aim Description
This study will test whether the wakefulness medication called Modafinil improves stroke-related fatigue and quality of life in a large group of stroke survivors. Participants will receive either 200 mg of Modafinil or placebo (an identical tablet with no active ingredient) for 56 days. There is a 50% chance of being in either of these groups.
Patients 18 years and older who have had a stroke at least 3 months ago and exhibit severe, persisting fatigue post-stroke.
Principal Investigator: Clinical Professor David Blacker
Enquiries Email: firstname.lastname@example.org